Intelsius Expands Cold-chain Pharma Packaging Line
Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions based in York, UK, announced the addition of its ORCA™ 2.0 range of products. The announcement was made today at the IQPC Cool Chain Logistics conference.
"We are extremely proud to raise the bar in thermal performance in adding these exceptionally high performing products to our portfolio and introduce them for the first time to logistic professionals at this, the largest and most well attended cool chain and temperature control event," said David Walsh , CEO DGP Intelsius. "Not only will the ORCA range benefit our customers in protecting their valuable payloads, but a portion of the proceeds of each unit sold in Europe will be donated to our chosen whale and dolphin charity partner, ORCA," Walsh said.
The ORCA 2.0 line is a high performance range of solutions that provides 170 plus hours of superior thermal protection for high value, temperature sensitive payloads. The entire ORCA 2.0 range is ATMOS™ (Analytical Thermal Modeling Software) enabled allowing quick risk assessment for the suitability of ORCA on routes around the world.
"The ORCA 2.0 range utilizes our advanced Plantol™ Phase Change Material (PCM) that allows the ORCA 2.0 solutions extended duration in both extreme hot and cold environments with simple pre-conditioning. The versatility of panel configurations for this line allows for cost effective, extraordinary performance right off the shelf," Walsh said.
The partnership with the ORCA charity aligns the growing global presence of Intelsius and its commitment to environmental stewardship. Founded in 2000, ORCA is a marine conservation charity dedicated to forging links between people and the sea through the study of whales, dolphins and porpoises. "We are proud to lead the way in developing the best performing solutions that protect patient safety worldwide, while also helping to understand and protect our marine environment," Walsh said.
Incorporated in 1998, Intelsius is a subsidiary of DGP Life Science Ltd, headquartered in York, United Kingdom. Intelsius serves a variety of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries to major laboratories. The company offers a variety of solutions to ensure the integrity of customers' products and samples. Intelsius has a growing global presence with manufacturing facilities, distribution hubs and local offices situated throughout the world, including North America, Europe and Asia.